Nephros, Inc. (NASDAQ:NEPH – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 11,100 shares, a growth of 1,750.0% from the October 15th total of 600 shares. Based on an average daily volume of 11,600 shares, the days-to-cover ratio is currently 1.0 days. Approximately 0.1% of the company’s stock are short sold.
Hedge Funds Weigh In On Nephros
A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP bought a new stake in Nephros, Inc. (NASDAQ:NEPH – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned approximately 0.17% of Nephros at the end of the most recent reporting period. 41.10% of the stock is owned by hedge funds and other institutional investors.
Nephros Stock Up 1.9 %
NEPH traded up $0.03 during trading on Tuesday, hitting $1.64. 5,461 shares of the company traded hands, compared to its average volume of 15,139. The firm has a market cap of $17.29 million, a P/E ratio of -17.89 and a beta of 1.19. Nephros has a one year low of $1.36 and a one year high of $4.04. The stock’s fifty day moving average is $1.62 and its 200 day moving average is $1.94.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on Nephros
About Nephros
Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
Read More
- Five stocks we like better than Nephros
- Investing in Commodities: What Are They? How to Invest in Them
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Plot Fibonacci Price Inflection Levels
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.